GlassScriptPhysician profile
Edward J Park
NPI 1366795106
$4,681.36
in general payments reported to CMS, 2019-2025
36 companies · $13.89 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $52.51 · 2020: $354 · 2021: $766 · 2022: $2,747 · 2023: $606 · 2024: $142 · 2025: $13.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $762.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $762.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $1,937.07 | 2022 | |
| Boston Scientific Corporation | $225.04 | 2021-2022 | |
| Astellas Pharma US INC | $221.36 | 2020-2022 | |
| Myovant Sciences INC. | $211.37 | 2021-2022 | |
| Abbvie INC. | $201.82 | 2020-2025 | |
| Laborie Medical Technologies Corp. | $174.26 | 2022 | |
| Procept Biorobotics Corporation | $159.88 | 2021-2023 | Aquabeam Robotic System |
| Tolmar, INC. | $149.89 | 2023 | |
| Sumitomo Pharma America, INC. | $128.70 | 2023 | Orgovyx |
| Pfizer INC. | $128.11 | 2020-2021 | |
| Progenics Pharmaceuticals, INC. | $123.38 | 2021-2023 | Pylarify |
| Endo Pharmaceuticals INC. | $111.01 | 2019-2023 | Xiaflex, Aveed |
| Acerus Pharmaceuticals Corporation | $96.28 | 2020-2022 | |
| Janssen Biotech, INC. | $91.43 | 2021-2022 | |
| Teleflex LLC | $70.97 | 2021-2023 | Urolift |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $66.12 | 2021 | |
| Accord Healthcare, INC. | $62.60 | 2023-2024 | |
| Blue Earth Diagnostics | $57.42 | 2020-2021 | |
| Myriad Genetic Laboratories, INC. | $55.84 | 2020-2021 | |
| C. R. Bard, INC. & Subsidiaries | $49.74 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $43.94 | 2021-2022 | |
| Allergan, INC. | $33.09 | 2019-2021 | |
| Antares Pharma, INC. | $29.16 | 2021 | |
| Novartis Pharmaceuticals Corporation | $25.85 | 2023 | |
| Ethicon US, LLC | $24.93 | 2020 | |
| Urogen Pharma, INC. | $23.97 | 2022 | |
| Alnylam Pharmaceuticals INC. | $23.50 | 2021 | |
| Curium US LLC | $22.02 | 2023 | |
| Merck Sharp & Dohme LLC | $21.11 | 2022 | |
| Becton, Dickinson and Company | $19.57 | 2024 | Bard Urinary Drainage Bag |
| Urovant Sciences INC | $18.92 | 2022 | |
| 180 Medical, INC. | $16.63 | 2019 | |
| Coloplast Corp | $16.58 | 2022 | |
| Sagent Pharmaceuticals | $14.21 | 2021 | |
| Olympus America INC. | $13.68 | 2022 | |
| Srs Medical Systems, INC. | $11.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.